Significant Ownership of New Enterprise Associates 15, L.P.

Signature - Title
/s/ Zachary Bambach - Zachary Bambach as attorney-in-fact for Anthony A. Florence Jr., Managing Partner and Co-Chief Executive Officer
Location
Timonium, MD
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by New Enterprise Associates 15, L.P..

Follow Filing Activity

Follow New Enterprise Associates 15, L.P. and return when a new Schedule 13D/G filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sponsored

Significant Ownership of New Enterprise Associates 15, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SNTI Senti Biosciences, Inc. Common Stock, $0.0001 par value 14% $11,968,700 3,775,615 New Enterprise Associates 15, L.P. 06 Mar 2025
SNTI Senti Biosciences, Inc. Common Stock, $0.0001 par value 12% 3,775,615 New Enterprise Associates 15, L.P. 27 Mar 2026
ACLX Arcellx, Inc. Common Stock $0.001 par value per share 5.3% $208,192,230 3,055,360 0% Scott D. Sandell 22 Feb 2026
NEUE NeueHealth, Inc. Common Stock, $0.0001 par value 0% $0 -$50,344,650 0 -100% New Enterprise Associates 15, L.P. 02 Oct 2025

Schedules 13D/G Reported by New Enterprise Associates 15, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.